Loading provider…
Loading provider…
Neurology Physician in Tampa, FL
NPI: 1265455315Primary Practice Location
TAMPA GENERAL HOSPITAL
1 Tampa General Cir, Tampa, FL
Primary Employer
University Medical Service Association Inc
health.usf.edu
HQ Phone
Get MD Theresa's Phone NumberMobile
Get MD Theresa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1993 - 2026
NY State Medical License
1991 - 1994

American Board of Psychiatry and Neurology
Neurology
Rutgers New Jersey Medical School
njms.rutgers.edu
Medical School
Until 1988
SUNY Downstate Health Sciences University
downstate.edu
Residency • Neurology
1989 - 1992
Rutgers Health
Internship • Transitional Year
1988 - 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 109 | 132 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 50 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 35 | 35 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 5 | 64616Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | 19 | 36 |
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Authors: L Wecker, M Engberg, R Philpot, C Lambert, C Kang, J Antilla, P Bickford, C Hudson, T Zesiewicz, Peter Rowell
Publication Date: 2012-12-18
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
Lead Sponsor: VA Office of Research and Development
Intervention / Treatment: DRUG: Quetiapine, DRUG: Pimavanserin
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: BIIB132-Matching Placebo, DRUG: BIIB132
Lead Sponsor: Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: CX-8998